Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes (Q38455623)
Jump to navigation
Jump to search
scientific article published on 21 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes |
scientific article published on 21 February 2013 |
Statements
1 reference
Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes (English)
1 reference
1 reference
Brian Zambrowicz
1 reference
Zhi-Ming Ding
1 reference
Ike Ogbaa
1 reference
Kenny Frazier
1 reference
Phillip Banks
1 reference
Anne Turnage
1 reference
Joel Freiman
1 reference
Melinda Smith
1 reference
Dennis Ruff
1 reference
Arthur Sands
1 reference
David Powell
1 reference
21 February 2013
1 reference
1 reference
273-285.e7
1 reference
Identifiers
1 reference